ASRT is no longer actively traded. Data shown reflects verified historical relationships.
2Suppliers
0Customers
3Debt Items
5Related Chains

Assertio Holdings, Inc. Suppliers

TickerNameConfidenceEvidence
HANMI-PHARMACEUTICAL-CO-LTD HANMI-PHARMACEUTICAL-CO-LTD 92% The Company depends on Hanmi Pharmaceutical Co., Ltd. as the qualified supplier for the active pharmaceutical ingredient in ROLVEDON
AQST Aquestive Therapeutics, Inc. 85% Reciprocal relationship from AQST graph: Reciprocal relationship from ASRT graph: Reciprocal relationship from AQST graph: Reciprocal relationship from ASRT graph: Reciprocal relationship from AQST g…

Assertio Holdings, Inc. Customers

No clients on recordNo downstream customers found in our database for Assertio Holdings, Inc..

Assertio Holdings, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ASRT-DEBT-7900 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.
ASRT-DEBT-7899 Warrants outstanding: 0.0016 90% xbrl warrant detail from xbrl 2021-12-31.
ASRT-DEBT Debt stack $40.3M 90% Market cache reports total debt of $40.3M.

Assertio Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Assertio Holdings, Inc..

Assertio Holdings, Inc. Ownership

HolderNameConfidenceEvidence
ASRT-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 3 tracked holders.

Assertio Holdings, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SPRY ARS Pharmaceuticals, Inc. 100.00 2
AQST Aquestive Therapeutics, Inc. 36.29 1 ['supplier']
ZEVRA ZEVRA 23.09 2
ZVRA Zevra Therapeutics, Inc. 20.60 2
HYPERA HYPERA 20.60 2